Determining the length of posttherapeutic follow-up for cancer patients using competing risks modeling.

Somda, Serge M A; Leconte, Eve; Kramar, Andrew; Penel, Nicolas; Chevreau, Christine; Delannes, Martine; Rios, Maria; Filleron, Thomas

Somda, Serge M A; Leconte, Eve; Kramar, Andrew; Penel, Nicolas; Chevreau, Christine; Delannes, Martine; Rios, Maria; Filleron, Thomas.

Afiliação

Somda SM; Institut Claudius Regaud, Toulouse Cedex, France (SS, CC, MD, TF).
Leconte E; Centre MURAZ, Bobo Dioulasso, Burkina Faso (SS)
Kramar A; TSE (GREMAQ), Universite´ Toulouse, Toulouse, France (EL)
Penel N; Centre Oscar Lambret, Lille, France (AK, NP)
Chevreau C; Centre Oscar Lambret, Lille, France (AK, NP)
Delannes M; Institut Claudius Regaud, Toulouse Cedex, France (SS, CC, MD, TF).
Rios M; Institut Claudius Regaud, Toulouse Cedex, France (SS, CC, MD, TF).
Filleron T; Centre Alexis Vautrin, Vandoeuvre-le` s-Nancy, France (MR)

Med Decis Making ; 34(2): 168-79, 2014 02.

Article em En | MEDLINE | ID: mdl-23811759

Assuntos

Neoplasias da Mama/terapia; Modelos Teóricos; Seguimentos; Humanos; Risco

Palavras-chave

Gompertz distribution; cancer; competing risks modeling; posttherapeutic follow-up

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Modelos Teóricos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Med Decis Making Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google